- Home
- AIG vs GEHC Comparison
AIG vs GEHC Comparison
Compare AIG & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIG | GEHC |
|---|---|---|
| Founded | 1919 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.8B | 36.0B |
| IPO Year | 2006 | 2022 |
Fundamental Metrics
Financial Performance| Metric | AIG | GEHC |
|---|---|---|
| Price | $78.12 | $82.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 22 |
| Target Price | ★ $88.00 | $87.85 |
| AVG Volume (30 Days) | 4.1M | ★ 4.2M |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.47% | 0.19% |
| EPS Growth | ★ 350.23 | 4.84 |
| EPS | ★ 4.78 | 3.44 |
| Revenue | ★ $26,775,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $9.65 | $6.01 |
| Revenue Next Year | $6.99 | $4.87 |
| P/E Ratio | ★ $17.09 | $24.94 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $71.25 | $58.75 |
| 52 Week High | $87.35 | $89.77 |
Technical Indicators
Market Signals| Indicator | AIG | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 73.36 |
| Support Level | $73.58 | $60.90 |
| Resistance Level | $78.58 | $85.55 |
| Average True Range (ATR) | 1.66 | 2.36 |
| MACD | -0.31 | 1.22 |
| Stochastic Oscillator | 4.02 | 75.05 |
Price Performance
Historical ComparisonAbout AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).